Ixabiso leFektri laseTshayina i-Anti-Villin Rabbit Polyclonal Primary Antibodies

inkcazo emfutshane:


  • Ixesha lovavanyo:imizuzu eli-10-15
  • Ixesha Elisebenzayo:Iinyanga ezingama-24
  • Ukuchaneka:Ngaphezulu kwe-99%
  • Inkcazo:Uvavanyo/ibhokisi eyi-1/25
  • Ubushushu bokugcina:2℃ -30℃
  • :
  • Iinkcukacha zeMveliso

    Iithegi zeMveliso

    Sithatha "indlela elungele abathengi, egxile kumgangatho, edibanisayo, neyintsha" njengeenjongo. "Inyaniso nokunyaniseka" yeyona ndlela ifanelekileyo yolawulo lwethu kwiFactory Price China Anti-Villin Rabbit PolyclonalAma-antibodies aphambili, Siza kubamkela ngentliziyo iphela bonke abathengi abasuka kushishino, ekhaya nakwamanye amazwe, ukuba basebenzisane, baze bavelise ikamva eliqaqambileyo elibonakalayo kunye.
    Sithatha "ubuchule kubathengi, ugxile kumgangatho, ukuhlanganisa, ukuvelisa izinto ezintsha" njengeenjongo. "Inyaniso nokunyaniseka" yeyona nto ifanelekileyo kulawulo lwethuI-Antibody Eyintloko yaseTshayina, Ama-antibodies aphambili, Iqela lethu lobunjineli abafanelekileyo ngokubanzi liya kuba likulungele ukukunceda ukuze ufumane iingcebiso kunye nempendulo. Sikwazile ukukunika neesampuli zasimahla ukuhlangabezana neemfuno zakho. Imizamo emihle iya kwenziwa ukuze sikunike inkonzo kunye nempahla engcono kakhulu. Ukuba unomdla kwishishini lethu kunye neemveliso, kufuneka uthethe nathi ngokusithumelela ii-imeyile okanye usitsalele umnxeba ngokukhawuleza. Ukuze wazi iimveliso zethu kunye nenkampani yethu, ungaya kumzi-mveliso wethu ukuze uyibone. Ngokuqhelekileyo siya kwamkela iindwendwe ezivela kwihlabathi liphela kwishishini lethu ukuze sakhe ubudlelwane boshishino nathi. Nceda uzive ukhululekile ukuthetha nathi ngamashishini amancinci kwaye sikholelwa ukuba siya kwabelana ngamava angcono okurhweba nabo bonke abathengisi bethu.
    I-CEA

    cal_conew1

     

    Iimveliso Iinkcukacha ikhowudi iyunithi uluhlu oluthe tye uluhlu lwesalathiso Uluhlu olunemigca
    Ikhithi yokuxilonga i-Carcino-embryonic antigen 25T/Ibhokisi I-Cea ng/ml 2-500 5

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     


  • Ngaphambili:
  • Okulandelayo: